ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,116Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 298

$556K Total Retail Price of All Prescriptions

Rank: 18 out of 298

589 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,260 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 662 620 1 2
LEVOTHYROXINE SODIUM 447 430 2 1
LOSARTAN POTASSIUM 427 405 3 18
OMEPRAZOLE 402 379 4 3
AMLODIPINE BESYLATE 388 366 5 6
ATORVASTATIN CALCIUM 257 234 6 14
FUROSEMIDE 232 220 7 5
SYNTHROID 232 209 7 42
METOPROLOL SUCCINATE 219 219 9 12
LISINOPRIL 207 184 10 4
POTASSIUM CHLORIDE 183 167 11 11
METFORMIN HCL ER 180 159 12 57
ALENDRONATE SODIUM 172 165 13 21
LOSARTAN-HYDROCHLOROTHIAZIDE 159 155 14 44
HYDROCHLOROTHIAZIDE 150 146 15 13
CITALOPRAM HBR 150 127 15 17
TRAMADOL HCL 149 110 17 15
PAROXETINE HCL 139 120 18 48
METOPROLOL TARTRATE 138 135 19 9
SERTRALINE HCL 132 110 20 19
MELOXICAM 130 121 21 41
ATENOLOL 123 118 22 16
WARFARIN SODIUM 112 96 23 7
GABAPENTIN 104 83 24 20
TRIAMTERENE-HCTZ 97 82 25 43
DONEPEZIL HCL 96 96 26 22
ALLOPURINOL 89 89 27 28
CLOPIDOGREL 88 86 28 36
NAMENDA 87 87 29 35
MIRTAZAPINE 85 79 30 37
FAMOTIDINE 65 63 31 80
EXELON 64 64 32 132
METFORMIN HCL 64 64 32 10
PLAVIX 63 61 34 70
BYSTOLIC 63 58 34 127
TRAZODONE HCL 61 61 36 39
CIPROFLOXACIN HCL 60 57 37 56
LANTUS SOLOSTAR 58 58 38 93
AMLODIPINE BESYLATE-BENAZEPRIL 57 56 39 98
ZOLPIDEM TARTRATE 56 47 40 25
BENAZEPRIL HCL 54 52 41 52
ISOSORBIDE MONONITRATE ER 53 53 42 45
PRAVASTATIN SODIUM 53 45 42 31
HYDROCODONE-ACETAMINOPHEN 51 34 S3 44 8
PREMARIN 50 47 R 45 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.